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Abstract
Linear peptide antibiotics have been isolated from amphibians, insects and humans and used as templates to design
cheaper and more potent analogues for medical applications. Peptides such as cecropins or magainins are940 amino acids in
length. Many of them have been prepared by solid-phase peptide synthesis with isotopic labels incorporated at selected sites.
Structural analysis by solid-state NMR spectroscopy and other biophysical techniques indicates that these peptide antibiotics
strongly interact with lipid membranes. In bilayer environments they exhibit amphipathic K-helical conformations and
alignments of the helix axis parallel to the membrane surface. This contrasts the transmembrane orientations observed for
alamethicin or gramicidin A. Models that have been proposed to explain the antibiotic and pore-forming activities of
membrane-associated peptides, as well as other experimental results, include transmembrane helical bundles, wormholes,
carpets, detergent-like effects or the in-plane diffusion of peptide-induced bilayer instabilities. ß 1999 Elsevier Science B.V.
All rights reserved.
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1. Introduction
The widespread increase in resistance of bacteria
and fungi against many of the commonly used anti-
biotics has raised interest in the discovery and devel-
opment of new compounds that yield e⁄cient pro-
tection when infections occur. Fortunately, peptide
antibiotics are found in many species including am-
phibians, insects or humans, and the discovery of
new active compounds has often been a result of
the investigation of nature’s gifts [1^5]. Analysis of
these compounds indicates that a large variety of
hydrophobic and amphipathic peptide antibiotics
are synthesised, stored and secreted in considerable
quantities. The availability of these substances estab-
lishes a defence system that can be set into action
immediately when infections occur. Understanding
the structure^function relationship of these peptides
allows for the design of cheaper and more e⁄cient
analogues [6,7]. The systems of particular interest for
pharmacological applications are those which exhibit
immunological or tumoricidal activity, but, under the
same experimental conditions, do not show haemo-
lytic or cytotoxic activity against healthy vertebrate
cells.
The scope of this article is to review some of the
structural studies, with emphasis on solid-state NMR
experiments, applied to membrane-active peptides. In
order to correlate the structural and functional char-
acteristics of these peptides, however, discussion of
results obtained by other techniques is essential.
A common characteristic observed for membrane-
active peptides is their capability to disturb bilayer
integrity, either by disruption or pore formation. The
resulting openings in the lipid bilayer lead to the
collapse of the transmembrane electrochemical gra-
dients and, therefore, can explain the cell-killing
activities of these peptides (reviewed, e.g., in [5,6,
8^10]). The formation of pores deprives sensitive
organisms of their source of energy and results in
increased water and ion £ow across the mem-
brane concomitant with cell swelling and osmolysis
[11,12]. A detailed understanding of the mech-
anisms of channel formation and cell lysis will allow
for the rationale design of new antibiotics in the
future.
The availability of e⁄cient analytical and prepara-
tive techniques has allowed the application of many
biophysical methods for the study of these peptides
(reviewed in [6,7]). These include X-ray crystallogra-
phy, NMR spectroscopy in solution and in the pres-
ence of lipid bilayers, as well as FTIR, Raman, £uo-
rescence and CD optical spectroscopies. Solid-phase
peptide synthesis is a versatile technique that allows
one to obtain high yields of peptide [13,14]. The
combination of solid-state NMR spectroscopy and
chemical methods has proven particularly powerful,
as the latter allow for the incorporation of isotopic
labels at single sites as well as modi¢cations of the
peptide sequence almost at will.
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Many of the membrane-active peptide antibiotics
have been synthesised and puri¢ed by chemical or
biochemical methods in quantities su⁄cient for con-
formational and functional analyses. Although struc-
tural studies at high resolution are prerequisites to
understanding the functional mechanisms of mem-
brane-active peptides, it should be kept in mind
that structural methods provide a view of the pep-
tide^lipid macromolecular complexes in their low-en-
ergy equilibrium states. The functional properties ob-
served may, however, be the result of a minor
population of the peptide in rarely-occurring higher
energy con¢gurations. It is, therefore, the critical as-
sessment of both structural and functional studies
that will ultimately allow one to understand the func-
tional mechanisms of these peptides.
The detailed chemical environment exhibits a large
e¡ect on the structure of short linear polypeptide
chains. The crystallographic analysis of these biomol-
ecules is hampered by this conformational dynamics
and, even within the same crystallising solution, crys-
tals with di¡erent unit cell dimensions have been
observed [15]. In order to study the functional mech-
anisms of peptides in a sensible manner, therefore,
the choice of experimental parameters is essential.
The 26-amino-acid amphipathic peptide melittin,
for example, adopts di¡erent degrees of helicity and
varies in its tertiary fold when investigated by X-ray
crystallography [16], NMR spectroscopy in organic
solution [17,18], in the presence of micelles [19,20], or
in association with lipid bilayers [21,22]. Polypeptides
strongly associated with phospholipid bilayers have
been investigated by solid-state NMR spectroscopy.
This technique provides information on the second-
ary structure, the orientation and penetration with
respect to the membrane surface (topology), as well
as the peptide dynamics (e.g., [23]). In addition, the
e¡ects of membrane-associated peptides on the mac-
roscopic phase properties of the membranes, the lipid
head-group conformations or the fatty acyl chain
packing have also been studied by solid-state NMR
spectroscopy (e.g., [24^26]). The characterisation of
peptide^lipid interactions by structural methods in-
cluding solid-state NMR spectroscopy, therefore,
forms the basis from which mechanistic models for
antibiotic and pore-forming activities can be devel-
oped.
2. Solution and solid-state NMR spectroscopy to
investigate membrane peptides
The solubility of amphipathic or hydrophobic
polypeptides is often insu⁄cient in aqueous bu¡ers
for investigating these biomolecules by solution
NMR spectroscopy, and organic solvents have there-
fore been used. Mixtures with tri£uoroethanol (TFE)
are thought to mimic the membrane environment
more closely than water alone, since TFE is moder-
ately hydrophobic and known to enhance the inher-
ent helical propensities of polypeptides [27]. How-
ever, the use of detergent micelles in aqueous
bu¡ers seems a much better choice when the mem-
brane interface is to be simulated during solution
NMR experiments [19]. Since the correlation times
of DPC or SDS micelles are similar to those ob-
served for large soluble proteins of 20^30 kDa, 1H
NMR spectra of small peptides in micellar solutions
are characterised by resonance line widths of typi-
cally 15^30 Hz [23,28,29]. Thus spectral overlap
and the lack of direct information on J-couplings
makes the conformational analysis of peptides in mi-
cellar environments more di⁄cult and the resulting
structures are usually less well de¢ned. Nevertheless,
several peptide antibiotics have been investigated in
the presence of detergent micelles using solution
NMR spectroscopy [7,30,31].
Whereas molecules in solution quickly reorient re-
taining only their ‘isotropic’ values, the nuclear in-
teractions with the magnetic ¢eld are inherently ani-
sotropic [32]. The correlation times of small peptides
associated with large macromolecular assemblies,
such as phospholipid membranes, are to a large ex-
tent determined by the size of the complex. Tumbling
is, therefore, considerably slower when compared to
this same peptide in solution. In order to obtain in-
formation about the structure and dynamics of pep-
tides associated with extended lipid bilayers, solid-
state NMR spectroscopic methods have been devel-
oped.
The anisotropic contributions of the chemical
shift, the dipolar and the quadrupolar interactions
often constitute the most pronounced features of
solid-state NMR spectra. The 15N chemical shift ani-
sotropy of a single static site, for example, covers
approximately 175 ppm [33,34] (Fig. 1C). This is
an order of magnitude greater than the dispersion
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Fig. 1. Calculated proton-decoupled 15N solid-state NMR spectra of helical peptides 15N-labelled at a single site and reconstituted
into oriented membranes (illustrated to the right of the spectra). The membrane normal is aligned parallel to the magnetic ¢eld direc-
tion (arrows). (A) Transmembrane orientation of the helix axis. (B) Orientation of the peptide approximately perpendicular to the
magnetic ¢eld direction. (C) Powder pattern line shape where a random distribution of molecular orientations has been assumed. The
15N chemical shift is scaled to liquid NH3.
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in the isotropic 15N chemical shift dimension ob-
served for the amide bonds of a protein in solution
(15 ppm). The resulting broad lines of immobilised
samples tend to show a high degree of signal overlap
when they are merely transferred into test tubes and
solid-state NMR spectra recorded. On the other
hand, the magnitude and the orientational depen-
dence of nuclear interactions provide valuable infor-
mation about the dynamics, the molecular structure,
and the orientation of peptides associated with lipid
bilayers.
In order to illustrate the orientational dependence
of the solid-state NMR spectra measured from static,
oriented samples, Fig. 1 shows simulations of 15N
NMR spectra recorded from membrane-associated
peptides labelled with 15N at a single amide bond.
The anisotropic chemical shift interactions are math-
ematically described by second rank tensors. The
amide 15N chemical shift tensor embedded within
the chemical structure of an K-helix are represented
graphically by an ellipsoid in Fig. 1A,B. The three
main axes of the ellipsoid represent the main tensor
elements c11, c22 and c33. The chemical shift that is
measured at a certain orientation of the molecule
corresponds to the length of a vector parallel to the
magnetic ¢eld direction, starting at the centre of the
ellipsoid and ending at the intersect of the magnetic
¢eld vector with the coat of the ellipsoid. Fig. 1A
exhibits a situation where the long axis of the ellip-
soid (c33 component of the 15N chemical shift tensor)
is aligned close to parallel to the NH bond vector/
helix axis. The molecules, therefore, exhibit 15N res-
onances at values s 200 ppm (Fig. 1A). The short
axes of the ellipsoid (c22 and c11 main tensor ele-
ments) correspond to chemical shifts of 85 ppm
and 65 ppm, respectively [33^35]. Chemical shifts in
this order of magnitude, therefore, indicate that the
magnetic ¢eld direction is oriented within the plane
de¢ned by the c11 and c22 vectors, i.e., perpendicular
to the main axis of K-helical conformations. Fig.
1A,B illustrates the functional dependence of 15N
chemical shifts for helical peptides. It should be
noted, however, that the conformational analysis of
membrane-associated polypeptides by oriented solid-
state NMR spectroscopy is not limited to the pres-
ence of helical secondary structures, as the nuclear
interactions exhibit a functional dependence on the
alignment of chemical groups, such as the amide
bond, with respect to the magnetic ¢eld direction.
If the secondary structure of the peptide is known
from CD, FTIR, Raman, solution, or solid-state
NMR spectroscopies (reviewed in, e.g., [6,7]), the
15N chemical shifts su⁄ce to approximately orient
the polypeptide domains with respect to the surface
of uniaxially aligned lipid bilayers (Fig. 1A,B) [36^
39]. Samples in which all orientations in space are
present exhibit ‘powder pattern’ line shapes (Fig.
1C). These are composites of the resonances of all
individual molecules and their line shapes are, there-
fore, determined by the molecular distribution as
well as by the functional dependence between the
chemical shift and the molecular orientation.
A detailed analysis of protein structures from
solid-state NMR measurements requires that the
size of the main tensor elements, as well as their
direction within the molecular co-ordinate system,
are known. The proton-decoupled 15N chemical shift
tensors for alanine or glycine amides have been
studied in considerable detail for a large series of
polypeptides [34,35,40^42]. These tensors show
some modest dependence on the secondary structure
of the polypeptide chain and the nature of the amino
acid side chain. Small variations in the tensor ele-
ments have been included into the error margin dur-
ing quantitative analyses of tilt angles from static
solid-state NMR spectra [36,39].
The dipolar coupling between two nuclei is anoth-
er important interaction that exerts a strong in£u-
ence on the appearance of solid-state NMR spectra
and which has been used to derive structural infor-
mation. The dipolar interaction D is a function of
the distance r between these nuclei, and the angle 3
of this vector r with respect to the magnetic ¢eld
direction:
DO3cos
2331
r3
When samples are mechanically rotated at high
speeds around the ‘magic angle’, the anisotropic con-
tributions of dipolar and chemical shift terms cancel
(3cos2331 = 0 at 3= 54.7‡), causing magic angle
spinning (MAS) NMR spectra to resemble ‘isotropic’
spectra [32]. The 15N and 13C chemical shifts have
been used to determine the structure of the polypep-
tide main chain [41,43]. Important structural infor-
mation, including the size of the dipolar coupling or
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the molecular orientation in space are, however, lost.
Therefore, magic angle spinning NMR techniques
have been developed that selectively reintroduce the
dipolar interaction term (reviewed in [44^46]).
Whereas peptide dynamics have been studied in
non-oriented samples [23,31,35,47], investigations of
the conformation and topology of polypeptides by
static NMR techniques requires the uniaxial orienta-
tion of membranes with respect to the magnetic ¢eld
direction. Phospholipid membranes orient mechani-
cally when applied onto glass plates [48], or magneti-
cally when phospholipids are mixed with bicelle-in-
ducing detergents [49]. This latter approach requires
a careful adjustment of the sample temperature and
composition. Interesting new developments suggest
that the magnetic alignment of lipid bilayers will be-
come a versatile approach for the uniaxial orienta-
tion of hydrophobic polypeptides in membranes
[50,51]. Till now, however, solid-state NMR spectros-
copy has relied heavily on the preparation of me-
chanically aligned samples. After the polypeptide^
lipid mixtures have been applied onto several thin
cover glasses of, for example, 11U22 mm, the sam-
ples are equilibrated for several days in an atmo-
sphere of de¢ned humidity (typically s 90% r.h.)
and stacked on top of each other. The resulting ori-
ented lipid bilayers are well hydrated, although bulk
water in between the hydration shell of the lipids is
absent. The lipid binding equilibria, therefore, tend
towards the membrane-associated state and the pep-
tides exhibit anisotropic mobility. When well-aligned
membranes are introduced into the NMR spectrom-
eter with the bilayer normal parallel to the magnetic
¢eld direction (B0), the main axis of rotational dif-
fusion coincides with the B0 vector. This set-up
avoids the introduction of additional peptide orien-
tations concomitant with broadened resonances from
rotational di¡usion. The line shapes of these NMR
spectra are a function of the orientational distribu-
tion of molecules with respect to the magnetic ¢eld
direction (mosaic spread), contributions from confor-
mational heterogeneity and the dynamic interchange
between di¡erent membrane topologies [23,28,39].
2.1. The gramicidin A structure by solid-state NMR
spectroscopy
Although hopes were initially raised that gramici-
din A, a 15 residue peptide of the soil bacterium
Bacillus brevis, would be useful as a cure against
mortal infections such as tuberculosis, it has proven
to be too toxic for application as a therapeutic agent
[52,53]. Nevertheless, a short discussion of this pep-
tide is included in this review. It was the pioneering
work of Tim Cross and co-workers who, using this
molecule in oriented phospholipid bilayers, demon-
strated that solid-state NMR spectroscopy is capable
of determining complete structures of membrane poly-
peptides at atomic resolution. To our knowledge the
structure of gramicidin A is so far the ¢rst and only
conformation submitted to a protein database that
has been determined solely from solid-state NMR
spectroscopic data. The detailed understanding of
the structure and dynamics of the gramicidin channel
in lipid bilayers provides a sound basis to understand
how ions are selected and transported across mem-
branes in a controlled manner. Whereas the 15N
chemical shift information from oriented membrane
samples alone is su⁄cient to determine the approx-
imate alignment of secondary structure elements with
respect to the membrane surface [36,37], measure-
ment of more than one interaction per peptide
bond allows for a detailed analysis of the peptide
secondary structure. Using oriented solid-state
NMR spectroscopy, the 15N^1H (or 15N^2H) and
15N^13C1 dipolar couplings have been determined
from singly or doubly labelled gramicidin A samples,
respectively. From this information possible orienta-
tions of the peptide plane with respect to the mag-
netic ¢eld direction (bilayer normal) were calculated
[54,55]. The 15N and 13C chemical shifts [54,56], 2H
quadrupolar splittings [57,58] as well as the known
geometries of peptide bonds were used as additional
structural ¢lters to reduce the number of possible
solutions [55]. When consecutive peptide bonds are
linked together, the tetrahedral geometry about the
CK position and information about the CK^2H ori-
entation further reduce the number of possible solu-
tions to a small set of four torsion angular pairs P/8.
For gramicidin all P/8 solutions are located in the L-
region of the Ramachandran plot [54,55,57,59]. Am-
biguities remain as the measured solid-state NMR
parameters are indi¡erent to the magnetic ¢eld point-
ing up or down in laboratory frame (chirality) as well
as to rotation of the dipolar vectors around the mag-
netic ¢eld direction. Although several discrete solu-
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tions for the orientation of each amino acid residue
are selected by this initial analysis, only four closely
related structures of the gramicidin molecule remain
after assembling together the peptide planes [54,55].
Structural re¢nement was performed using 120 ori-
entational backbone constraints and hydrogen bond-
ing distances. In order to carry out these calcula-
tions, some of the initial assumptions such as ¢xed
geometry and perfectly planar structure of the pep-
tide bond were relaxed, and this resulted in a single
averaged structure [55]. Gramicidin A assumes a
transmembrane right-handed L-helix with 6.5 resi-
dues per turn when reconstituted into membranes
[55]. This unusual polypeptide conformation is the
result of alternating L- and D-amino acids in the gra-
micidin A sequence. As one of these helices is capa-
ble of spanning a lipid monolayer only, head-to-head
dimerisation results in a stable transbilayer pore
(26 Aî ).
In order to accurately calculate structural param-
eters from the chemical shift information of oriented
spectra, knowledge of the e¡ective tensor in the pep-
tide environment is required. The detailed investiga-
tion of the 15N chemical shift interaction tensors has
been achieved using non-oriented samples of syn-
thetic peptides labelled at single sites and reconsti-
tuted into hydrated membranes. Whereas the back-
bone tensors of gramicidin A show little
orientational variation within the molecular frame
(6 þ 2‡) [60], the chemical environment as well as
global and local motional averaging a¡ect the size
of the tensor interactions [35,60]. These tensor char-
acterisations not only made the accurate interpreta-
tion of orientational constraints possible, at the same
time, the detailed dynamics of the labelled sites were
also determined. The availability of single-site la-
belled samples from chemical peptide synthesis has
been of key importance in these studies, as at present
it is not possible to obtain this important set of data
from samples with multiple labels.
Furthermore, the conformation, dynamics and ori-
entation of all side chains of gramicidin A were de-
termined. This was achieved by oriented 2H solid-
state NMR of deuterated valine [61,62] and leucine
residues [54]. In addition, the structure of the trypto-
phan side chains has been studied by 13C, and a
combination of 15N and 2H solid-state NMR spec-
troscopies [63,64]. Solid-state NMR spectroscopy
alone, however, did not always provide su⁄cient in-
formation to unambiguously resolve the structure of
these side chains. In these cases the restraints, togeth-
er with torsion angle energies, allowed the selection
of the ‘most probable’ conformations.
The gramicidin A channel supports a single-¢le
column of water inside its 4 Aî wide pore. Passage
of an ion, therefore, requires replacement of one of
these water molecules and correlated movement of
ions and water through the channel. Whereas the
presence of anions does not show any e¡ect on the
solid-state NMR spectra of gramicidin, monovalent
cations exhibit a pronounced in£uence on the chem-
ical shifts of the most water-exposed carbonyls of
Leu10, Leu12 and Leu14 [65,66]. However, other
amino acids, as well as the tryptophan side chains,
remain largely una¡ected by the addition of cations
[63,66]. Due to the large channel diameter and the
polarisation e¡ects observed in the presence of
monovalent cations, it has been concluded that the
monovalent cation binding site is delocalised over the
interaction volume of the Leu10, Leu12 and Leu14
carbonyls. The lack of large structural alterations at
the primary binding site of the ion prevent a deep
potential energy well which would result in a reduced
dissociation rate [66]. The carbonyls merely replace
water molecules and, upon penetration of the ion
into the channel, dehydration has been suggested to
occur in an incremental manner until only two of six
water molecules of the primary hydration sphere re-
main associated with the ion [66]. The helical ar-
rangement of backbone carbonyls around the inner
channel wall is suggestive for an o¡-axis helical
transport pathway through the pore [67]. The tight
association of water molecules with divalent cations
provides a mechanism to prevent passage of these
ions. A related ion selectivity ¢lter has been detected
in the X-ray structure of the 17.6 kDa KscA potas-
sium channel from the soil bacterium Streptomyces
lividans [68]. This protein forms a tetrameric arrange-
ment in which selectivity for K is achieved by spe-
ci¢c interactions of this ion with the main chain car-
bonyls of a 12 Aî long region (instead of, e.g.,
charged side chains).
The global rotational reorientation of gramicidin
A is temperature dependent and occurs at correlation
times of approximately 1039^1034 s [69^73]. The lo-
cal dynamics of gramicidin A have been investigated
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with the help of ¢eld-dependent T1 relaxation meas-
urements on oriented peptide samples in liquid crys-
talline lipid bilayers [74]. Librational motions of ap-
proximately þ 6‡ around the CK^CK axis of adjacent
amino acids occur on a 10-nanosecond time scale,
thereby correlating with the time scale of translocat-
ing ions from one carbonyl to the next [74]. Further-
more, picosecond and subpicosecond dynamics
around the same axis reduce the c22 and c33 compo-
nents of the powder patterns [35]. These backbone
librations occur with amplitudes of þ 14‡ to þ 22‡ at
low temperatures (6 263 K) and strongly increase at
the ¢nal turn of the helix above the ice melting tem-
peratures (283 K). Librations of carbonyls into the
channel lumen seem important as they allow the
passing sodium ions to maintain a solvating environ-
ment.
Studying the tryptophan indole 15NO powder pat-
terns as a function of temperature indicates that
these side chains, although ¢xed in a rotameric state,
exhibit librations of the tryptophan side chains by
19^29‡ around the M2 axes. These side chain dynam-
ics modulate the dipolar interaction strength which is
e¡ective at the channel mouth by about 4 kJ/mol
[75,76]. Such £uctuations could form a rapid gate
for conductance by helping to release the ion into
the pore. At the same time signi¢cant components
of the tryptophan indole dipole moments reduce
the rate-limiting energy barrier for ion passage at
the monomer^monomer junction in the centre of
the pore [76,77]. By reviewing the solid-state NMR
data, it becomes clear that the detailed analysis of
the structure and dynamics of the gramicidin A
channel, although of simple and unique composition,
has provided many valuable insights into the mech-
anisms of transmembrane channel formation.
In contrast to the transmembrane alignment of
gramicidin A dimers, the solid-state NMR structural
data measured from the antibiotic peptide magainin
2 are only in agreement with a right-handed K-helix
when compared to other low-energy secondary struc-
tures [78]. The helix axis of this polypeptide is ori-
ented parallel to the membrane surface and, there-
fore, does not reach through the bilayer. The
puzzling question of how this peptide forms pore-
like structures will be addressed in the next section.
2.2. Linear peptide antibiotics from insects and
amphibians
As pathogenic organisms become increasingly re-
sistant to the commonly applied antibiotics, there has
been considerable interest in discovering and explor-
ing the utility of natural antibiotic peptides by them-
selves, or as templates to design derivatives for phar-
maceutical and agricultural purposes [14,79,80].
Amphipathic peptides are found in many species in-
cluding insects, amphibians, humans or plants (re-
cently reviewed in [3^6,9,10,80,81]). These peptides
show bactericidal, fungicidal, virucidal and tumorici-
dal activities without lysing cells of healthy eucar-
yotes (e.g., [82^84]). The best studied of these pep-
tides are probably the members of the bombinin-
magainin (or ‘PGS’) family ¢rst found in toads and
frogs [85^87], and the cecropins isolated from the
pupae of the cecropia moths [88,89]. Polypeptide se-
quences are shown in Table 1. A 31-amino-acid
mammalian analogue, cecropin P, has also been iso-
lated [90,91]. Whereas magainins are stored in gran-
ula in the skin of frogs, cecropins are induced upon
infection. Both these peptide families, therefore, pro-
vide a fast innate host defence system [1,2]. The ac-
Table 1
Amino acid sequences of channel-forming peptides
KWKLF KKIEK VGQNI RDGII KAGPA VAVVG QATQI AK^CONH2 Cecropin A
GMASK AGAIA GKIAK VALKA L^CONH2 PGLa
GIGKF LHSAK KFGKA FVGEI MNS^CONH2 PGS (Magainin 2)
KWKLF KKIGI GKFLH SAKKF^CONH2 CA(1^8)^MA(1^12)
KWKLF KKIGI GAVLK VLTTG^CONH2 CA(1^8)^ME(1^12)
GIGAV LKVLT TGLPA LISWI KRKRQ Q^CONH2 Melittin
KKALL ALALH HLAHL ALHLA LALKK A^CONH2 LAH4
Ac^UPUAU AQUVU GLUPV UUEQF^OH Alamethicin
U, K-methylalanine; CONH2, C-terminal carboxyamine; OH, C-terminal amino alcohol; Ac, N-terminal acetyl.
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tivity of naturally occurring combinations of some
members of this peptide family, such as PGLa
and magainin 2, are more potent than the equiv-
alent amounts of either of these peptides alone,
indicating a synergistic enhancement of activity
[92^94]. Similarly, cecropin^melittin or cecropin^
magainin hybrid peptides are more active by up to
two orders of magnitude in antibiotic assays when
compared to native cecropins [95,96]. The peptide
hybrids nevertheless retain the lack in haemolytic
activity.
Both magainins and cecropins have been shown to
exhibit pronounced e¡ects on cellular energy metab-
olism, suggesting that they exhibit their cytotoxic
activity by disrupting the electrochemical gradient
across energy-transducing membranes [97^99]. The
presence of 0.6^3 mol% magainin 2 results in the
half-maximal decoupling of the respiratory free-
energy transduction of bacterial or spermatozoal
cells, isolated mitochondria, or reconstituted cyto-
chrome oxidase liposomes ([100] and refs. cited there-
in). However, no simple correlation has become evi-
dent between antibacterial activity and the
uncoupling of the respiratory phosphorylation in mi-
tochondria when the concentration dependent e¡ects
of cecropins have been tested [98]. A high coverage
of bacterial membranes has been detected when ra-
dioactively labelled cecropins develop their bacterio-
toxic activity [101]. Resistant bacteria, however, are
loaded with cecropins to a similar extent whereas
non-permissive erythrocytes are not. Therefore, fac-
tors other than merely the binding a⁄nity must also
play an important role in determining the suscepti-
bility of cells to these bacteriotoxins [98,101].
All-D-magainins, all-D-cecropins, cecropins with in-
verted sequences (retro) or inverse D-cecropins (retro-
enantio), all possess the high antibiotic and the pore-
forming activities of the parent L-enantiomer
[13,102,103]. These ¢ndings indicate that the cell-kill-
ing activities of these amphipathic peptides are not
mediated through speci¢c, chiral receptor interac-
tions. Direct peptide^lipid interactions have, there-
fore, been suggested as being the underlying mecha-
nism for the peptides’ biological activities.
Electrophysiological investigations of planar mod-
el membranes indicate that the conductivity for ions
augments in the presence of cecropins or magainins
[104^107]. The increases in step-wise conductivity
during electrophysiological experiments described
by some authors [104,105,108] was taken as an indi-
cation for pore formation by transmembrane helical
bundles [109^112], in analogy to the mechanism pro-
posed for the hydrophobic peptide alamethicin
[6,113] (Fig. 3A). A large range of conductivities of
the pores, starting at 1.8 pS and ranging over three
orders of magnitude, has been detected for magainin
2 [105,108]. The size of these channels varies within
each electrophysiological recording as well as from
experiment to experiment. Whereas magainin ‘chan-
nels’ in PC/PE 7:3 membranes are anion-selective
(ratio PK/PCl = 1:3) [108], a selectivity of cations
over anions (5:1) exists in mixed PE/PS 1:1 mem-
branes [105]. Small anion selectivity (Cl3/Na 2:1)
was also observed for the large channels (2.5 pS)
formed by cecropin AD [104]. Selectivity within the
respective class of monovalent ions was not detected
in any of the published electrophysiological experi-
ments. In addition, these channel events are rare and
short lived [105,107,108]. Magainin-induced electro-
physiological events have, therefore, been described
as ‘occasional brief multilevel £uctuations’ (at 0.1
mg/ml), or, at higher peptide concentrations, as ‘me-
littin-like bilayer disruptions’ [107].
In the absence of transmembrane potentials, mag-
ainin or cecropin-magainin peptides have been
shown to cause the release of the £uorescence dyes
calcein (Mr 623) or 6-carboxy£uorescein/Co2 from
large or small unilamellar vesicles [114^116]. Simi-
larly, a cecropin A^melittin hybrid permeabilises mi-
tochondrial inner membranes both in the presence or
absence of transmembrane potentials [117]. Interest-
ingly, the permeability of ions increases already at
lipid-to-cecropin ratios s 200; the release of £uoro-
phores from vesicles or of cellular constituents, on
the other hand, requires much higher amphiphile
concentrations [10,99,118].
Magainin (PGS) polypeptides consist of 21- to 26-
amino-acid residues some with strongly basic charac-
ter. These peptides dissolve well in aqueous solution
where they assume random coil conformations. They
also show a strong a⁄nity for phospholipid mem-
branes where they assume right-handed K-helical
conformations (Fig. 2, reviewed in [6]). Interestingly,
this lack of secondary structure before membrane
insertion seems an important factor for e⁄cient anti-
biotic activity of cationic peptides [119]. On the other
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hand, the cell-lytic activities of cecropins correlate
with the formation of K-helical secondary structures
in membrane environments as well as with their
binding a⁄nity to liposomes [120].
MAS solid-state NMR distance measurements us-
ing the 15N decouple, 13C detect REDOR technique
were used to measure intramolecular distances be-
tween labelled sites of magainin 2 and agree with
K-helical conformations of magainin 2 in the pres-
ence of DPPG/DPPC 1:1 bilayers [121]. At high pep-
tide-to-lipid ratios, however, K-helix and L-sheet con-
tributions have been shown to co-exist using ATR^
FTIR and 13C MAS^NMR spectroscopies [121]. For
these experiments the lipid-to-peptide ratio was as
high as 11.4 (mol/mol) and the samples had been
lyophilised, frozen or the lipids were in their gel
phase, respectively.
Similarly, cecropin A assumes a predominantly
random coil conformation in water [88,122]. In
15% hexa£uoroisopropanol (v/v) cecropin A ex-
hibits two K-helical regions (residues 5^21 and
24^37) that are interconnected by a £exible hinge
region near proline 24 [123]. Whereas the central
part of the C-terminal helix (residues 25^33) is hy-
drophobic, the length and the continuous distribu-
tion of basic residues along one face of the amphi-
pathic N-terminal helix closely resembles the amino
acid distribution of magainins (Fig. 2). Similar struc-
tures in organic solvents are also found for a mixed
peptide consisting of the ¢rst 13 N-terminal amino
acids of cecropin followed by the 13 N-terminal res-
idues of melittin [79,124], or cecropin-like peptides
[125^127]. The mammalian analogue cecropin P,
on the other hand, lacks the £exible hinge region
[128]
In order to analyse the structure and alignment of
magainin antibiotic peptides in planar lipid bilayers,
proton-decoupled 15N solid-state NMR spectroscopy
has been performed on oriented samples of magainin
2 [78] and PGLa [31]. Several peptides have been
synthesised by chemical methods, each labelled at a
single residue throughout their sequence. The pep-
Fig. 2. Edmundson helical wheel diagrams of cecropin A (residues 5^21); CE-MA: cecropin A(1^8)^magainin(1^12); CE-ME: cecro-
pin A(1^8)^melittin(1^12); PGS (magainin 2); PGLa; and LAH4 (residues 3^23). Charged amino acids are circled.
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tides have been reconstituted into mechanically
aligned bilayers, equilibrated at 93% relative humid-
ity and introduced into the solid-state NMR spec-
trometer with the membrane normal parallel to the
magnetic ¢eld direction. The 15N chemical shifts of
eight labelled residues of magainin 2 occurred
around 80 ppm (relative to liquid NH3), indicating
an orientation of the NH vector approximately per-
pendicular to the magnetic ¢eld direction (membrane
normal). Additional multidimensional solid-state
NMR experiments allowed for the measurements of
both the proton-decoupled 15N chemical shift, the 1H
chemical shift, as well as the 1H^15N dipolar cou-
pling of four consecutive residues (14^18) [78,129].
All measured parameters are dependent on the ori-
entation of the labelled peptide bond with respect to
the magnetic ¢eld direction and can, therefore, be
used to calculate the secondary structure of this re-
gion when associated with lipid bilayers. Only right-
handed K-helical conformations agree with the meas-
urements among all low-energy secondary structures
tested [78]. Proton-decoupled 15N solid-state NMR
spectra obtained at magainin 2 concentrations of
0.8^3 mol% from eight residues between positions 2
and 20 suggest that in lipid bilayers the K-helix ex-
tends to the terminal regions of the peptide [78].
Edmundson helical wheel analysis shows that such
a helix is amphipathic with the polar and hydropho-
bic amino acid side chains separated on opposite
faces of the helix (Fig. 2). Intercalation of this helix
into the bilayer interface in an in-plane fashion,
therefore, allows for both hydrophobic and electro-
static interactions to be satis¢ed.
The extension of helical structures into the peptide
terminal regions, as observed by oriented solid-state
NMR spectroscopy, seems to contrast the much low-
er degree of helicity derived from optical spectros-
copies. These latter techniques, however, test for
the conformational average of peptide dissolved in
the water phase (random coil) and peptide associated
with the membrane (highly K-helical). As these meas-
urements are performed with dilute samples, the
presence of negatively charged lipids is required to
enhance the membrane a⁄nity of the basic peptides
by electrostatic attraction [130]. In contrast, the ori-
ented samples used in solid-state experiments are
characterised by a reduced bulk water content and
the experimental set-up allows one to focus on the
immobilised polypeptide sample by using cross-pol-
arisation pulse sequences [131].
The 15N chemical shifts obtained from oriented
magainin 2 samples furthermore indicate that the
K-helix is oriented with its long axis parallel to the
membrane surface [36,37]. This in-plane alignment
has been observed for a wide variety of lipid compo-
sitions, including bilayers of POPE/POPG 3:1 or
POPC/POPG/cholesterol 3:1:4, i.e., with lipid com-
positions that mimic procaryotic and eucaryotic
membranes, respectively [26]. In-plane orientations
of magainin 2 at 3 mol% concentrations have also
been observed by ATR-FTIR spectroscopy in dry
oriented samples [132] and by oriented CD spectros-
copy [133]. In addition, £uorescence quenching ex-
periments of magainin derivatives, where the three
phenylalanines of magainin 2 are independently re-
placed by tryptophans, con¢rm the in-plane orienta-
tion observed with 15N solid-state NMR spectros-
copy [134]. These experiments indicate that all
three £uorescent probes are localised approximately
10 Aî equidistant from the bilayer centre. Peptide
insertion into the membrane was also monitored by
photolabelling techniques [135]. The solid-state
NMR results were taken as an input to optimise
computer programmes which use molecular simula-
tions to determine the conformation, penetration and
orientation of bilayer-associated peptides [136,137].
The localisation of these peptides at the membrane
surface have furthermore been con¢rmed by fast
deuterium exchange monitored by FTIR spectros-
copy as well as REDOR magic-angle spinning sol-
id-state NMR spectroscopy [121]. The latter experi-
ments indicate a close distance between labelled 13C
residues in the centre of the peptide and the immo-
bilised head groups of DPPC/DPPG 1:1 membranes.
This data contrasts the results obtained by oriented
CD spectroscopy, which indicate transmembrane he-
lix alignments in the presence of DMPC/DMPG 3:1
at full hydration and peptide concentrations s 3
mol% [133]. Topological di¡erences may be due to
experimental parameters such as hydration and lipid
composition. Alternatively, the possibility remains
that at high peptide-to-phospholipid ratios macro-
scopic phases di¡erent from extended lipid bilayers
exist which explain both experimental ¢ndings.
Multidimensional solution NMR spectroscopy in
micelles, in combination with solid-state NMR spec-
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troscopy on phospholipid bilayers, indicates that the
peptide antibiotic PGLa also assumes K-helical con-
formations that are oriented parallel to the mem-
brane surface [31]. X-ray di¡raction experiments pro-
vide supporting results [138]. Whereas the C-
terminus of this peptide strongly associates with lipid
bilayers, the local dynamics in the presence of POPC
increases toward the N-terminus in agreement with
helix propensity calculations [138]. The narrow ani-
sotropies of the proton-decoupled 15N spectra of un-
oriented samples which is observed for 15N-Ala3 and
15N-Ala6, indicate that these residues of PGLa ex-
hibit a high degree of mobility on the time scale of
the solid-state NMR experiments (1033^1034 s). This
result also indicates that at 93% r.h., the hydration of
oriented bilayer stacks is su⁄cient to allow the reor-
ientational freedom of the peptide terminus. Using
double D-amino acid replacements, the K-helical con-
formations of the magainin 2 N-terminus were also
shown to be less stable in the presence of liposomes
when compared to the C-terminus [139]. Similarly,
the C-terminus of cecropin(1^8)^magainin(1^12) hy-
brids exhibit a higher propensity to form helical
structures when compared to the N-terminus [140].
Taken together, these results suggest repulsive inter-
actions between the positive pole of the helix dipole
(N-terminus) and charged lysine side chains that de-
stabilise the helix conformation.
ATR^FTIR spectroscopy and molecular dynamics
calculations show that the continuous helix of cecro-
pin P [128] exhibits orientations parallel to the mem-
brane surface as well [141,142]. Similarly, cecropin A
is predominantly oriented in the plane of lipid bilayer
stacks [143]. The structural and functional similar-
ities between several cecropins, PGLa and the mag-
ainins suggest that these develop their antibiotic and
pore-forming activities by similar mechanisms. The
importance for biological activities of residues within
the amphipathic N-terminal helix, as well as within
the £exible linker region of cecropin, seems to sup-
port such a suggestion [101,104,122,144]. The long
list of related sequences might further include other
amphipathic peptide antibiotics such as Abp3 [126],
bombinin [85,145], bombolitin [146], buforins [147],
caerin [148], ceratoxins [127], dermaseptins [10,149],
gaegurins [150], maculatin [151], pexiganan [152],
PMAP-37 [153], Shiva-3 [154], and designed sequen-
ces [139,155,156].
Although the secondary structure and the func-
tional properties of cecropins and magainins have
been characterised by a multitude of techniques,
the mechanism of antibiotic action and increases in
electrical conductivity across lipid bilayers is still a
matter of speculation. In fact, there seems to be a
discrepancy between the experimental data indicating
in-plane alignments of amphipathic peptides and the
suggested formation of channels by transmembrane
helical bundles. This discrepancy would be reconciled
if the majority of the peptides resided on the mem-
brane surface with only a minor fraction interacting
in a transmembrane fashion, or if other models were
to be applied [6]. In order to evaluate these possibil-
ities, a quantitative understanding of the peptide-
peptide and peptide^lipid interactions in membranes
is necessary. With the estimated Gibbs free energy of
transition between in-plane monomers and channel-
forming transmembrane aggregates, the equilibrium
constant and the ratio of peptide populations in
transmembrane versus in-plane alignments can be
calculated [23]. This result allows the comparison
of the estimated probabilities of channel formation
with experimental results.
2.3. Amphipathic model peptides with pH-dependent
orientations
Amphipathic model peptides not only exhibit pro-
nounced antibiotic activities [156^158], but they also
allow one to study in considerable detail the various
interaction contributions relevant for peptide topo-
logical order [6,23]. In order to better understand
the mechanisms of pore formation and antibiotic ac-
tivities of amphipathic peptides, K-helical sequences
have been designed in our laboratory. These helices
are characterised by a hydrophobic face separated
from a more polar region of variable composition
‘X’ by four histidines (Fig. 2). The polarity of these
histidine side chains is strongly dependent on the pH
of the surrounding medium, therefore many of these
peptides exhibit pH-dependent transitions between
transmembrane and in-plane alignments [23,132,159].
Assuming a simple two-state equilibrium for the
reorientational process, the equilibrium constant is
calculated according to K = [TM]/[IP], where [TM]
is the concentration of transmembrane peptide and
[IP] the concentration of peptide in in-plane align-
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ments [23]. The Gibbs free energy that governs such
a process is calculated according to the equation:
vG  vGh  vGd  vGp  vG#;
with vGh being changes in hydrophobic interactions
during the transfer process, vGd the energy required
to discharge an amino acid side chain at a given pH,
vGp the contribution of placing a polar but un-
charged side chain in the hydrophobic membrane
interior, and vG# the sum of changes in all other
interactions such as hydrophobic mismatch energies,
the energies of fatty acyl chain conformational
changes during the adaptation to the polypeptide
surface, the lipophobic e¡ect [160], or van der Waals
interactions that occur during the process in-plane
Ctransmembrane. Inherent in the above equation
is the assumption that it is more favourable to re-
move the charge from an amino acid side chain be-
fore placing it in the bilayer interior. This notion is
supported by comparing the Born energy of placing
a charge in a low dielectric environment [161] with
the sum of the energies of discharging an amino acid
at neutral pH and consecutively placing a polar but
uncharged residue in the membrane interior [6,23].
From the chemical potentials of the Lewis acid or
base of amino acid side chains, it is possible to cal-
culate the energy to discharge a base at any given pH
according to:
vGd  ni RT ln r 2:3RT
X
i
pKi3pH;
where i represents the amino acids that are dis-
charged, ni their total number and RT ln r amounts
to approximately 11.5 kJ/mol [6,23]. The energy re-
quired to discharge the histidines of our model pep-
tide is, therefore, a linear function of the di¡erence
between the pK of the side chain and the pH of the
environment.
LAH4, the ¢rst peptide of this family, has been
investigated by oriented 15N solid-state NMR as
well as ATR^FTIR spectroscopies [23,132]. For this
peptide a transition midpoint of around pH50 = 6.3
has been determined by analysing either the chemical
shift distribution or the dichroic ratio of the amide I
and amide II bands. Two well-separated lines are
visible in proton-decoupled 15N solid-state NMR
spectra, indicating that the transmembrane and the
in-plane peptide populations exchange slowly on the
NMR time scale (1034 s). Interestingly, the antibiotic
activity of this peptide is an order of magnitude more
pronounced at pH 5.5 when compared to magainin 2
[156]. At low pH both peptides are predominantly
oriented along the membrane surface [23,78]. When
the pH is increased to neutral, LAH4 changes into
transmembrane orientations and at the same time
looses much of its antibiotic activity [156]. Magainin
2 or the LAK4 analogue of LAH4 show pH-inde-
pendent activity similar to that of LAH4 at low
pH. These results suggest that the antibiotic action
of amphipathic peptides is independent of the forma-
tion of transmembrane helical bundles. This conclu-
sion is further supported by the pronounced antibi-
otic properties observed for K-helices consisting
solely of leucines and lysines (v11 residues) or of
small peptidomimetics which are too short to span
the membrane [155,157,162]. These peptides exhibit a
narrow orientational distribution parallel to the bi-
layer surface when investigated by proton-decoupled
15N solid-state NMR spectroscopy [163].
The hydrophobicity of residues X located at the
polar face of the peptide exhibit a strong in£uence
on the transition pH of these peptides (at pH50,
vG = 0). It has been shown, for example, that the
transitions of leucine-containing peptides are shifted
to lower pH when compared to alanine-containing
peptides [159]. This e¡ect has been used to calculate
the relative hydrophobicities of single amino acids.
In contrast to the commonly used hydrophobicity
tables, this approach yields values for amino acids
that are part of helical polypeptides in bilayer envi-
ronments, instead of, for example, the transition en-
ergy of isolated amino acids between water and oc-
tanol [159].
Due to the importance of lysine residues in peptide
antibiotics, the topological e¡ects of this amino acid
has been investigated in some detail using amphi-
pathic model peptides. Peptides that consist of hy-
drophobic amino acids with more than three lysine
residues in the central region of the K-helix orient
along the membrane interface [164]. In the presence
of only one lysine residue transmembrane alignments
are observed. The latter result suggests that in a hy-
pothetical in-plane orientation, the lysine side chain
cannot snorkel to the surface without exposing a
considerable fraction of hydrophobic residues. The
resulting hydrophobic interactions are larger and op-
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posite in sign than the transfer energy of lysine
(waterCmembrane). Using the above formalism,
the transfer energy of lysine is composed of a hydro-
phobic term which arises from four methylene
groups, the energy to discharge a side chain at
(pK3pH) = 3.5, and the polar energy needed to
move an NH2-group into the hydrophobic interior
of the membrane [23,164].
2.4. Melittin
The peptide^lipid interactions of melittin (or mel-
litin), a peptide isolated from the European honey
bee Apis mellifera, have been studied in considerable
detail using a variety of techniques including solid-
state NMR spectroscopy. Although this peptide is
too haemolytic to be used as an antibiotic, the
many experimental data which have been published
for melittin exemplify important aspects of peptide^
lipid interactions. In addition, the comparison of me-
littin with other antibiotic peptides provides a guide-
line that helps to understand how selectivity between
haemolytic and antibiotic activities is achieved.
Melittin readily binds to red blood cells where the
peptides cause an increase in permeability for sodium
and potassium ions, as well as cell swelling and the
release of haemoglobin [11,12]. Conductance changes
and discrete multilevel conductances have also been
observed in the presence of this peptide (reviewed in
[8]). Melittin is characterised by 5^6 positive charges,
four of which are at the C-terminus. Transferred
NOE and deuterium exchange measurements indi-
cate that in the presence of lipid bilayers, melittin
adopts K-helical conformations between residues 6
and 10 as well as between 13 and 21 interconnected
by a £exible bend due to proline 14 [21,22]. At low
concentrations of peptide, the helix axis is predom-
inantly oriented parallel to the membrane surface
[21,165]. However, at peptide-to-lipid ratios of 1/12
to 1/14, oriented 13C solid-state NMR spectroscopy
of peptides (each labelled at a single site with 13C in
ten di¡erent locations between residues 2 and 20)
agree with K-helical peptides that exhibit transmem-
brane orientations [166]. These investigations are in
agreement with dynamical equilibria between the
peptide orientations which are functions of the phys-
ical state of the membrane [167^169].
The bilayer structure of liquid crystalline phospha-
tidylcholine (PC) is retained unaltered in the presence
of up to 5 mol% melittin. However, 2H and 31P solid-
state NMR, as well as ATR^FTIR spectroscopy, in-
dicate that the order parameters of the fatty acyl
chains decrease due to the presence of peptide
[8,24]. Furthermore, electrostatic interactions of 2H-
labelled phosphatidylcholine head groups with mem-
brane-associated surface charges has been monitored
in a quantitative manner using deuterium NMR
spectroscopy [170,171]. In the presence of melittin
the POPC interface senses an e¡ective charge from
the peptide of only about 2, although at neutral pH
melittin retains 4^6 positive charges [25,172]. A
super¢cial peptide insertion into PC membranes
might allow for an e⁄cient screening of charges in
the aqueous phase.
In the presence of intermediate amounts of melit-
tin (6 5 mol%), reversible micellisation concurrent
with magnetic orientation of the structures occurs
at temperatures below the liquid crystalline-to-gel
state phase transition of the pure lipid [24,173,174].
Freeze-fracture electron microscopy, light scattering
and gel ¢ltration indicate that disc-shaped micelles
with an approximate diameter of 235 Aî are formed.
These were suggested as consisting of 1500 bilayer
lipids which are surrounded by a melittin belt [173].
The observed bilayer deformations are probably a
result of the increased volume in the head-group re-
gion when melittin intercalates into the membrane
[16,175]. The disc-like PC micelles are metastable,
however, and transform into lamellar structures.
The fusion kinetics are dependent on the mismatch
between the bilayer hydrophobic thickness and the
length of the melittin helix and can last for several
days [24,176].
At high peptide concentrations both gel and liquid
crystalline bilayers are transformed into small ob-
jects. In the gel state, however, the bilayer disruptive
properties are only observed after pre-incubation of
large PC vesicles at temperatures above either the
gel-to-liquid crystalline phase transition [173] or the
pre-transition temperature [177]. With the help of
stopped-£ow £uorescence spectroscopy, the penetra-
tion of melittin into the hydrophobic region of the
membrane has been identi¢ed as the rate-determining
step during incorporation into liquid crystalline bi-
layers [178]. The melittin-induced macroscopic
changes of sphingomyelin membranes are qualita-
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tively similar to those observed for DPPC bilayers
[179].
The melittin-induced interconversion of membrane
structures during temperature alterations is less pro-
nounced in the presence of cholesterol [177,180]. It
has been suggested that a tightening of the mem-
brane prevents the insertion of melittin into the bi-
layer and that the molecular shape of cholesterol
counteracts the melittin-induced wedge e¡ect. The
presence of 30 mol% cholesterol, however, also sta-
bilises previously formed disc-like micelles. It has
been shown that cholesterol is redistributed between
the lamellar and the micellar phase during temper-
ature changes [180]. These molecules thereby provide
a bu¡er for a lipid order parameter that corresponds
to a constant disc hydrophobic thickness of 29 Aî .
Whereas melittin disrupts PC bilayers into small
structures, the peptide exhibits bilayer-stabilising ef-
fects when mixed with phosphatidylethanolamine
membranes under conditions where the pure lipid
arranges in a hexagonal phase (HII) [181]. Using a
variety of biophysical methods including NMR spec-
troscopy it has been estimated that the peptide is
localised at the membrane interface with the trypto-
phan-19 residue close to the glycerol backbone in the
presence of zwitterionic membranes [21,182^184].
The peptide, therefore, occupies a much larger space
at the level of the zwitterionic phospholipid head
groups. The combination of a membrane-inserted
short hydrophobic N-terminal helix and a surface-
anchored highly charged C-terminal segment was
suggested as an explanation for the particularly pro-
nounced wedge shape of melittin when compared to
other amphipathic molecules [185].
In contrast to observations with zwitterionic mem-
branes, for cardiolipin a transition of the bilayer into
HII (high temperature) or cubic phases (6 40‡C) is
observed due to the presence of melittin [186]. Mem-
brane insertion of melittin results in a preference for
inverted phases for this and other charged phospho-
lipids, including DOPA (HII) or egg-PG [187]. The
melittin £uorescence emission spectra have been used
to localise the W19 of melittin in the hydrophobic
interior of cardiolipin membranes [188].
When the surface charge density in the vicinity of
deuterium labelled phospholipids is monitored by 2H
solid-state NMR spectroscopy [170], it has been
shown that the positive charges of melittin compen-
sate for the negative surface charge density intro-
duced by the anionic lipids in mixed DMPC/DMPS
membranes (80:20 mol/mol). The 2H NMR spectra
indicate that the e¡ects of the peptide and lipid
charges cancel each other at a lipid-to-peptide-ratio
of 5:1, a value that is close to that expected from a
peptide carrying 5^6 positive charges [189]. Whereas
this former ternary system remains homogeneously
mixed, a partial phase separation in mixed DSPC/
DPPG bilayers was detected by £uorescence and
Raman spectroscopies [190]. Interestingly, acidic
phospholipids or fatty acids provide stabilising ef-
fects on PC lipid bilayers when melittin is present
[189,191,192]. Alterations in melittin membrane pen-
etration depth and/or di¡erent phospholipid head-
group geometries provide possible explanations for
these stabilising e¡ects.
2.5. Alamethicin
Alamethicin is a 20 amino acid fungal peptide of
Trichoderma viride (reviewed in [6,53,193,194]). The
alamethicin sequence consists of mostly hydrophobic
amino acids, including two prolines at positions 4
and 14. Structural analysis by X-ray crystallography
[195], NMR spectroscopy in methanolic solution
[196], or in the presence of SDS micelles [197] indi-
cate that the peptide adopts helical conformations
which are interrupted by the proline-14 residue.
The helix-breaking motif G-X-X-P introduces a £ex-
ible hinge region [197^200] with a 310 helical turn
between V15 and L12 in the crystal [195]. NMR ex-
periments indicate a less regular helix conformation
or considerable conformational averaging of the C-
terminal residues [196,197], in agreement with molec-
ular modelling calculations [201,202]. FTIR, Raman
and CD spectroscopies show that the degree of hel-
icity is dependent on the physical state of the lipid
[167], the lipid/peptide ratio [203] and the presence of
transmembrane potentials [204].
CD and Raman spectroscopies indicate that the
peptide alignment with respect to the surface of sup-
ported bilayers exhibits a complicated phase diagram
which is dependent on peptide concentration, the de-
tailed lipid composition, hydration, and the macro-
scopic phase of the membrane [167,205]. Proton-
decoupled 15N solid-state NMR spectroscopy was
performed with alamethicin labelled with 15N at the
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alanine-6 position and incorporated into uniaxially
DMPC bilayers at peptide-to-lipid ratios of 1:8
[206]. These experiments demonstrate that the pep-
tide is aligned in a transmembrane fashion and ex-
hibits rotational averaging around the membrane
normal. The 15N chemical shifts and 1H^15N dipolar
interactions agree with an K-helical but not a 310
helical conformation of the N-terminus. The e¡ect
of molecular oxygen and paramagnetic ions on
ESR spin label studies indicates that the N-terminus
of alamethicin, in an orientation parallel to the mem-
brane normal, remains 16 Aî distant from the head-
group phosphates of the opposing bilayer lea£et
[207]. It appears that hydrogen bonding interactions
of the less regular C-terminal helix anchor the pep-
tide at the bilayer interface [196,197,199,208]
When added to lipid bilayers, the polypeptide ex-
hibits voltage-dependent conductance changes sim-
ilar to those seen in the presence of large voltage-
or ligand-gated channel proteins (reviewed in
[6,53,193]). Under well selected patch-clamp condi-
tions more than 20 di¡erent channel states have
been observed [209]. The open alamethicin pore has
been suggested as consisting of 3^11 helical rods ar-
ranged around a water ¢lled pore, that form ‘trans-
membrane helical bundles’ or ‘barrel staves’ [193].
The best support for these models is derived from
the co-operativity observed in membrane partitioning
isotherms of alamethicin [210] and channel formation
[211], as well as the pattern of successive conductance
levels, each a few milliseconds long [113,212]. Start-
ing from the lowest observed values, the conductivity
of the black lipid membranes increases fast and in
well de¢ned steps of a few hundred picosiemens. The
step size becomes larger as the conductivity increases.
Transitions of a speci¢c size have not been observed
in conjunction with other states [113,193,212]. The
frequency of conductivity bursts increases with the
applied voltage, indicating that the macroscopic volt-
age dependence of alamethicin arises from the initial
formation of the lowest-level pore. These observa-
tions have been taken as an indication that the small-
est conducting structures consist of trimers (19 pS at
1 M KCl [213]) or tetramers (88 pS at 0.5 M KCl
[214]).
Analysis of the alamethicin multiple channel ki-
netics indicates that the conductance £uctuations oc-
cur on a millisecond time scale and within a burst of
channel openings. In contrast, the initial formation
and decay of the lowest conductance state is 10 to
100 times slower. The respective activation energies
are 50 and 120 kJ/mol [215].
Geometrical considerations indicate that a channel
which consist of, for example, 11 monomers results
in a diameter of 25.5 Aî and a conductivity of v4.4
nS. Such a big pore has lost most of the little cation
selectivity that is observed for the smaller channels
[193]. High ionic strength stabilises the lower conduc-
tance levels and increases the life times of all levels,
probably by decreasing the electrostatic repulsion be-
tween monomers that arise from like charges and/or
K-helical dipoles [216]. For example, a decrease in
channel activity is observed when the C-terminus of
alamethicin is chemically modi¢ed to carry three neg-
ative charges [217].
Various models for the molecular mechanism of
alamethicin voltage gating are based on interactions
of the alamethicin helix dipole with the electric ¢eld
(reviewed in [6,53,194,218]). The dipole moment of
alamethicin corresponds to a net +1/2 charge at the
N- and a 31/2 charge at the C-terminus of the helix
(75 Debye = 16 eAî , [219]). Whereas in most of the
suggested models voltage gating involves reorienta-
tion of part or all of the helix dipole, it has also been
observed that partitioning of alamethicin from solu-
tion into the membrane increases with the applied
transmembrane voltage [220].
3. Models for channel formation and antibiotic
activity
3.1. The transmembrane helical bundle model
The ‘classical’ picture to explain formation of
pores in planar lipid bilayers is the so-called ‘barrel
stave’ or ‘helical bundle model’ (Fig. 3A). This model
is often used to explain pore formation and step-wise
conductivity increases in single-channel measure-
ments. The best studied peptide for which the for-
mation of transmembrane helical bundles has been
suggested is alamethicin, a member of the family of
peptaibols. In contrast to the openings observed with
highly charged amphipathic peptides, the alamethicin
channels are reproducible and well de¢ned. The in-
terested reader is asked to refer to the above discus-
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sion on alamethicin to review important experimen-
tal details that form the basis of this model (cf.
supra).
Channel formation has been shown to occur and
oriented solid-state NMR spectroscopic measure-
ments support formation of transmembrane helical
bundles for the following peptides: HIV-1 protein
U [39], the transmembrane region of the related
M2 polypeptide of in£uenza A in the absence [38]
and presence of the antiviral drug amantadine
[163], or the putative channel lining fragment M2
of the acetylcholine receptor protein [36,221]. In
large protein channels, however, transmembrane
peptide sequences predominantly interact with other
amino acids, a situation that is not well represented
by the pure lipid matrix of the NMR samples.
Previous experiments indicate that the antibiotic
activities of amphipathic model peptides are not cor-
related with the transmembrane orientations of heli-
ces [156]. Other models which have been suggested
for antibiotic activity and pore formation are, there-
fore, presented below.
3.2. Wormhole model
Whereas the formation of transmembrane helical
bundles seems a reasonable model to explain the
well-de¢ned step-wise conductivity increases ob-
served for predominantly hydrophobic peptide se-
quences, such an arrangement results in the accumu-
lation of many lysine and arginine residues in a
highly restricted volume when bundles form of cati-
onic peptides. In the case of a magainin hexamer, for
example, 30 lysines would accumulate within a nar-
row pore of a few Aî ngstroms in diameter and ca. 30
Aî in length [6]. In addition, the cation selectivity of
pores formed by these latter peptides in the presence
of PE/PS 1:1 membranes [105] seems to contrast the
high positive charge density of the peptides. The
transmembrane helical bundle model has, therefore,
been modi¢ed, such that lipid together with peptides
line the walls of toroidal openings [222,223]. At high
peptide concentrations (s 3.3 mol% corresponding
to s 10 wt.%), neutron in-plane scattering experi-
ments on mechanically aligned membrane systems
indeed indicate that water-¢lled cavities are present
in the samples (named ‘wormholes’, Fig. 3B) [222].
However, the interpretation of such observations is
di⁄cult as the mosaic spread of the lipid and the
peptide components in oriented samples increases
at magainin concentrations s 3 mol% (Bechinger,
unpublished results). Moreover macroscopic phase
transitions that correlate with alterations in pep-
tide^lipid interactions have been observed at magai-
nin-to-lipid ratios v 3 mol% [133,135,224,225]. Fur-
ther increases in peptide concentration result in the
visible disintegration of the bilayers, probably into
bicelles [92,163]. Although the formation of worm-
holes has been suggested to be an intermediate step
during membrane micellisation and the development
of antimicrobial activities, the experimental condi-
tions of the neutron scattering experiments probably
do not re£ect the real situation in which channel-
formation is observed in electrophysiological studies
[105,107,108].
3.3. Carpet model
Models involving transmembrane orientations of
amphipathic peptides are di⁄cult to reconcile with
observations that designed amphipathic helices (8^
22 residues) show their strongest antibiotic activity
when they consist of only 11^15 leucines and lysines
[157]. The peptides with maximal antibiotic activities
are, therefore, too short to cross the membrane. This
observation is in agreement with solid-state NMR
and IR spectroscopic investigations which indicate
that these and related peptides are oriented parallel
to the membrane surface [163,226]. Furthermore, the
model peptide LAH4 (cf. supra) exhibits much higher
antibiotic activity at low pH, when oriented parallel
to the membrane surface, than at neutral pH where
the peptides adopt a transmembrane alignment [156].
Based on experimental results observed with the
peptide antibiotic dermaseptin, a third model has
been proposed [227]. This 34-residue peptide is rich
in lysines and can be con¢gured into an amphipathic
K-helix (residues 1^27), thereby resembling cecropins
and magainins. The peptide partitions into acidic and
zwitterionic membranes; association with neutral
membranes, however, happens with an apparent par-
tition coe⁄cient reduced by one order of magnitude
[227]. It has been suggested that in the presence of
negatively charged lipids and at high peptide concen-
trations, dermaseptin is located at the membrane sur-
face and self-associates in a ‘carpet-like’ manner (Fig.
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3C). This model further suggests that the membrane
breaks into pieces when a threshold concentration of
peptide is reached [10]. At an intermediate stage
wormhole formation has been suggested to occur
[10]. Transmembrane pore formation may be possi-
ble, but according to the authors of this model, is not
likely [227]. The presence of negatively charged lipids
is important for a peptide carpet to form, as they
help to reduce the repulsive electrostatic forces be-
tween positively charged peptides. In addition, high
local peptide concentrations are achieved when cati-
onic peptides phase-separate into domains rich in
acidic phospholipids [138,228,229].
3.4. Detergent-like e¡ects
The cytotoxic activity exhibited by cationic amphi-
philes is most simply explained by taking into con-
sideration their bilayer-disruptive properties. Disinte-
gration of the bilayer results in the loss of the
membrane barrier, dissipation of the transmembrane
electrochemical gradient, loss of cytoplasmic constit-
uents and interference with the energy metabolism of
living cells (Fig. 3D). In a similar manner, the release
of £uorescence dyes from model systems is probably
a consequence of the peptide-induced disintegration
of vesicular membranes. The onset of £uorescence
dye leakage takes place at magainin concentrations
of approximately 3 mol% which is equivalent to 81
g/mol lipid, a based-on-weight-value very similar to
those observed for the permeability increases in the
presence of the detergents Triton-X100 and octyl glu-
coside [114,230]. The initial asymmetric association
at the outer surface of the vesicle only results in an
enhancement of peptide-induced membrane instabil-
ities and biphasic £uorophore release kinetics
[114,231]. 31P solid-state NMR spectroscopy indi-
cates that addition of 2 mol% magainin to phospha-
tidylcholine bilayers results in the formation of an
additional isotropic phase [163]. Further increasing
the magainin 2 concentration leads to the clearance
of the magainin phospholipid suspension and the
appearance of phospholipid bilayers that are oriented
with their membrane normal perpendicular to the
magnetic ¢eld [92,163]. Similarly, addition of lysolip-
ids [232] or detergents [233] result in the disintegra-
tion of phospholipid bilayers as well as magnetic
orientation of bicelles [49]. In these latter structures
a patch of bilayer is stabilised by a rim of short-chain
lipids or detergents. Membrane disruptive properties
have also been observed for other amphipathic heli-
cal peptides such as melittin [173,234], apolipopro-
teins [235], myelin basic protein [236], glucagon
[237], signal sequences [238,239], and basic amphi-
philic model peptides [240]. Micellar structures can
either bud from the membrane at regions of high
local peptide density [10] (Fig. 3C) or when small
pre-formed peptide aggregates interact with lipid
membranes [156,163,241] (Fig. 3D).
On a molecular level the intercalation of peptides
between the phospholipid head groups corresponds
to insertion of a cone-shaped molecule into the mem-
brane (Fig. 3E). The head group of phosphatidyl-
ethanolamine occupies a smaller surface area in the
interfacial region, therefore, this lipid corresponds to
an inverted cone and more easily compensates for the
strain imposed on the bilayer by inserted peptides
[115,242] (Bechinger, unpublished results). Antibiotic
action due to the membrane-lytic properties of in-
plane oriented amphipathic peptide helices have
been discussed at previous occasions [10,92,99,117,
118,156,243,44]. The observation of step-wise con-
ductivity increases is, however, more di⁄cult to ex-
plain [4,6].
3.5. In-plane di¡usion model
Whereas the formation of carpet-like aggregates or
the detergent-like disintegration of membranes de-
serves consideration when high local concentrations
Fig. 3. Models for the occurrence of increases in conductivity across phospholipid membranes (‘pore formation’). See text for details.
(A) Transmembrane helical bundle of mostly hydrophobic polypeptides. (B) Wormhole model. (C) Carpet model. (D) In-plane di¡u-
sion model: peptide monomers are surrounded by areas of bilayer with irregular lipid packing characteristics. These di¡use along the
surface of the bilayer causing transient openings when zones of metastability overlap. Alternatively, the detergent-like action of amphi-
pathic peptides leads to the formation of peptide^lipid micelles, bilayer openings and the transient formation of pores. (E) The disrup-
tion of the lipid bilayer packing due to in-plane inserted peptides is schematically illustrated for monomers and side-to-side dimers.
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of membrane-associated cationic peptides are
present, comparatively low peptide-to-lipid ratios
are needed to dissipate the ionic gradient across
cell membranes or to develop antibiotic activity
[10,99,100,242]. A model has therefore been pro-
posed where lipid-mediated channel formation is
based on the curvature strain imposed on lipid mem-
branes in the presence of intercalated amphipathic
peptides. This model is independent of cationic pep-
tide aggregation, which is entropically and electro-
statically disfavoured even in the presence of nega-
tively charged phospholipids [6].
The diameter of a peptide helix is only about 12 Aî ,
and therefore insu⁄cient to span a lipid monolayer
(Fig. 3E). Fluorescence energy transfer measure-
ments indicate that the hydrophobic region of mag-
ainin 2 analogues, where phenylalanines have been
replaced by tryptophans, is located approximately
10 Aî from the bilayer centre [134]. The insertion of
in-plane peptides into lipid bilayers, therefore, leads
to disturbances in the bilayer packing within a diam-
eter of approximately 100 Aî and a reduction in the
average bilayer thickness [225,245]. Di¡usion of the
peptides within the membrane causes regions of in-
stability to overlap, disturbances of the lipid packing
to accumulate, and transient openings to occur [6]
(Fig. 3D). This latter model is in agreement with
experimental ¢ndings including the non-cooperative
membrane association of monomeric cecropins
[99,117,141,246], the lack of peptide association with-
in PG membranes which has been observed for mag-
ainin 2 at concentrations 95 mol% [247], the small
co-operativity observed for magainins and cecropins
in functional assays including channel formation
[105,110,111,130,228,272], the in-plane orientation
of amphipathic peptides [29,31,78,134,156], as well
as translocation of lipid and peptide through bilayer
openings or by di¡usion along the lipid surface
[231,248]. In addition, cecropin and magainin open-
ings are in marked contrast to the pores formed by
alamethicin (cf. supra). These former peptides show
weak ion selectivity, variability of the conductance
increases over three orders of magnitude, and the
£uctuations within each conductivity level
[104,105,108]. In addition, the permeability changes
in the presence of magainins are rare and di⁄cult to
reproduce, as would be expected for a model based
on molecular £uctuations [105,107,108].
Support for such a model is further derived from
the observation that short peptides such as masto-
paran (14 residues) [249], cecropin-melittin hybrids,
some as short as 15 amino acids [250], and synthetic
peptides (8^14 residues) [251^253] are also capable of
exhibiting channel-like activity, although these pep-
tide are too short to reach through the membrane.
Furthermore, the charged amphipathic peptide se-
quence S4 from the sodium channel proteins, exhibits
three conductance states at 70 pS, 300 pS and 500 pS
when added to zwitterionic or mixed PC/PS mem-
branes [254]. Interestingly, the ¢rst conductance level
is permanently open and, therefore, correlated to the
low-energy con¢gurations also observed by structur-
al methods. S4 exhibits K-helical secondary struc-
tures of 12 amino acids in length in membrane-like
environments [29,255]. This helix orients parallel to
the membrane interface as determined by proton-de-
coupled 15N solid-state NMR spectroscopy in lipid
bilayers, attenuation of NMR signal intensities by
micelle-associated nitroxide radicals, or molecular
modelling in a tetrachloromethane/water two-phase
environment [29]. The average distance between
chromophore-labelled S4 monomers or their location
within the membrane is una¡ected by transmem-
brane di¡usion potentials [228].
Step-wise conductivity increases have also been ob-
served in the presence of detergents [230,256], pure
lipid membranes [257^259], or small unilamellar
phospholipid vesicles when added to planar lipid bi-
layers [260], suggesting that an amphipathic distribu-
tion of charges and hydrophobic functional groups
can be su⁄cient for the observation of channel-like
events.
4. Regulation of antibiotic and channel activity
Regulation of selectivity and activities by peptide
antibiotics can occur at any stage during the multi-
step process of accession to the membrane, bilayer
association, insertion and pore formation: water
soluble H surface accessible H surface associated
H bilayer inserted H T H openings.
In order to develop cytolytic activity, the peptide
has to ‘survive’ exposure to serum or other media,
and pass di¡erent barriers such as the extracellular
matrix, or the bacterial lipopolysaccharides, outer
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membrane and/or peptidoglycan layers [80]. Once it
reaches the cell membrane its structures and topolo-
gies are in dynamic interchange [261,262]. The mem-
brane association and cell-killing properties of cati-
onic peptide amphiphiles are regulated by
electrostatic and hydrophobic interactions which af-
fect these multiple equilibria. Whereas the surface
charge density of lipid bilayers has been shown to
be of major importance for peptide association, the
transmembrane potential seems to have a much
smaller e¡ect on membrane lysis. If electrostatic in-
teractions are neglectable, such as in the outer lea£et
of erythrocyte membranes, hydrophobic interactions
become important. Biophysical investigations of
these interactions are described in more detail below.
It has been shown that the presence of negatively
charged lipids increases the local concentration of
cationic peptides close to the membrane surface
and therefore also their apparent association con-
stants [99,130,263]. Whereas the outer monolayers
of bacterial plasma membranes are rich in negative
phospholipids, the membranes of healthy vertebrate
cells appear neutral. Tumour cells, on the other
hand, have lost part of their lipid asymmetry and
therefore exhibit a more anionic character at their
exterior [264]. The many like-charges of the peptides,
however, also result in strong repulsive interactions.
This has a twofold e¡ect: ¢rst, the charges of the
peptide screen the negative surface charge density
of the lipid, therefore, the electrostatic contribution
to the binding isotherm is strongly dependent on the
amount of bound peptide and saturates at apparent
charge equality [25]; second, electrostatic repulsion
reduces the probability and life-time of peptide ag-
gregates [265]. As these interactions are long range,
the close approach of peptides and the formation of
aggregates may even be suppressed completely [6].
Electrostatic interactions also arise from the pres-
ence of large inside-negative transmembrane poten-
tials present in respiring procaryotic cells but not in
erythrocytes [266]. It has been suggested that trans-
membrane electric potentials a¡ect the partitioning
of polypeptides between the aqueous and the lipid
phase [220], the orientations of peptides within mem-
branes [193], and the peptide bilayer penetration
depth and polypeptide conformation [29].
Due to the composition of the outer lea£et of red
cell membranes and the negligible transmembrane
electric potential, electrostatic contributions are small
[157,266]. Association and membrane-lytic activities
of cationic amphiphiles are, therefore, governed by
hydrophobic interactions. These are functions of the
hydrophobic angle, the hydrophobic moment and the
overall hydrophobicity of the peptides [158,242,267].
Reduction of the hydrophobicity of cecropin^magai-
nin peptides correlates with decreases in haemolytic,
but not antibiotic or fungicidal activities [140,157]. It
has been shown that a large hydrophobic angle of
magainin-derived model peptides increases the mem-
brane permeabilising activity of the bound fraction
as well as the ratio of antibacterial over haemolytic
activities when keeping the hydrophobicity and the
hydrophobic moment constant. [242].
Cholesterol, which is only present in eucaryotic
cells, changes the interactions of cationic peptides
with the membrane. It was shown, for example,
that the incorporation of cholesterol into unilamellar
vesicles of Escherichia coli phospholipid decreases the
release of trapped glucose by cecropin analogues
[268]. The cecropin-related conductivity across phos-
pholipid membranes is also reduced due to the pres-
ence of cholesterol [104]. Cholesterol a¡ects the £uid-
ity and the dipole potential of phospholipid
membranes and therefore modulates the activity of
membrane-inserted peptides. In addition, the forma-
tion of hydrogen bonds between glutamates and cho-
lesterol has been suggested to reduce antibiotic activ-
ity [269]. Interestingly, cholesterol delays the cell lytic
e¡ects of cecropins without abolishing them, suggest-
ing that the peptide inserts more slowly into choles-
terol-containing membranes [99,101]. A slowing of
the insertion process or a modulated association be-
haviour might allow proteases to remove the toxins
from the cellular surface [80,85,99,270].
Once inserted into the membrane, the peptide^
lipid interactions, the composition of the phospho-
lipid head groups and the fatty acyl chains all pro-
vide further levers for regulating channel and anti-
biotic activities when lipid-mediated models apply.
Melittin, for example, has been shown to exhibit a
rich variety of peptide^lipid interactions (cf. supra).
The ability of amphipathic peptides to penetrate or
to disrupt the membrane are dependent on the
charge and the size of the lipid head group
[156,242]. Although acidic lipids increase the mem-
brane association of cationic peptides when taking
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into account the amount of membrane-bound pep-
tide only, it becomes obvious that the presence of PG
lipids exerts a deactivating e¡ect on their permeabil-
ising properties [156,242]. This indicates signi¢cant
di¡erences in their interaction mechanisms. In addi-
tion, the inherent curvature of bilayer phospholipids
may compensate or enhance the tendency for the
formation of non-bilayer structures [115,242]. This
is particularly true when the di¡usion-controlled for-
mation of bilayer defects is the underlying mecha-
nism (Fig. 3D). Comparing the e¡ects of magainin
2 on membranes with di¡erent phospholipid compo-
sition suggests these peptides impose positive curva-
ture strain in zwitterionic membranes [115,163,242].
Additional regulatory pathways arise from the
synergistic enhancements of antibiotic activities in
naturally occurring cocktails of peptide antibiotics
[10,93]. At 4 mol% total peptide concentration, the
analysis of membrane-association isotherms suggests
the formation of a stoichiometric 1:1 complex of
PGLa and magainin 2 [94]. It is interesting to note
that dimerised melittin allows £uorescence dye e¥ux
from PC SUV to occur at increased rates when com-
pared to monomeric melittin [271]. The authors of
this latter study suggest a bilayer perturbation model
similar to the one in Fig. 3D,E. Whereas the e¡ects
of a monomeric in-plane helix on the membrane are
bu¡ered by the surrounding lipids, a side-by-side in-
tercalated dimer occupies twice the area on the mem-
brane surface without a concomitant increase of the
number of surrounding lipids (circumference). Filling
the dimer induced defects by the lipids is, therefore,
considerably more di⁄cult. A similar model can ex-
plain the synergistic activity of combinations of other
amphipathic peptides [10,93,118].
5. Conclusions
The interactions of amphipathic peptide antibiotics
with lipid bilayers are characterised by a variety of
reversible equilibria. The interaction contributions
are electrostatic, hydrophobic, van der Waals and
entropic in nature. The Gibbs free energies that de-
scribe these equilibria are usually composites of large
quantities of opposite sign, and with our present
knowledge di⁄cult to assess in a quantitative man-
ner. Matters are further complicated as lipid mem-
branes are soft and capable of altering their geomet-
rical features and macroscopic phase preferences in
the presence of peptides. Nevertheless, a limited
number of models, some of which relate to each oth-
er, have been suggested to explain the macroscopic
structures of linear amphipathic peptides in mem-
branes. In fact, the same peptide might interact
with phospholipid membranes in di¡erent manners
depending on the peptide-to-lipid ratio, the lipid
composition of the membrane, the presence of salt
and other experimental details. With the help of bio-
physical methods such as solid-state NMR spectros-
copy, the conformation, topology and dynamics of
membrane-associated peptides and lipids have been
investigated in considerable detail. These techniques,
therefore, have provided a wealth of structural data
which allow a better understanding of the interac-
tions underlying antibiotic activity and pore forma-
tion. These results have subsequently been used for
the design of better and cheaper pharmaceuticals.
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